Use access key #2 to skip to page content.
$14.94 -0.14 (-0.93%)
8/21/2008 4:00 PM

Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:
****

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

1

Avatar rsgtomc (< 20) Submitted: 3/02/07 3:28 AM : Outperform Start Price: $11.83 MNTA Score: 35.04

MNTA has a excellent business plan for capturing a generic drug market of blockbuster drugs as sole generic provider. Their exclusive patented methods for analysing very complex compounds sets them apart from the competition in proving bioequivalence of theiir generic version for FDA approval.

Report this Post Replies: 0 | Reply

Featured Broker Partners